ALS: Synapse's breathing simulation device gets humanitarian approval, Brainstorm initiates stem cell trial
This article was originally published in Clinica
Executive Summary
The US FDA has granted a humanitarian use device approval for Synapse Biomedical's Neurx diaphragm pacing system (DPS) in amyotrophic lateral sclerosis (ALS).